Misoprostol use for second-trimester termination of pregnancy among women with one or more previous cesarean deliveries
| Autor: | W J Steinberg, Martin Cuellar Torriente, Gina Joubert |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
medicine.medical_specialty Administration Oral Young Adult 03 medical and health sciences Incomplete Abortion 0302 clinical medicine Pregnancy Retained placenta Humans Medicine 030212 general & internal medicine Misoprostol Retrospective Studies Reproductive health Abortifacient Agents Nonsteroidal 030219 obstetrics & reproductive medicine Cesarean Section business.industry Obstetrics Obstetrics and Gynecology Abortion Induced Retrospective cohort study General Medicine medicine.disease Uterine rupture Administration Intravaginal Regimen Treatment Outcome Pregnancy Trimester Second Female business medicine.drug |
| Zdroj: | International Journal of Gynecology & Obstetrics. 138:23-27 |
| ISSN: | 0020-7292 |
| DOI: | 10.1002/ijgo.12168 |
| Popis: | OBJECTIVE To establish the safety and efficacy of misoprostol for second-trimester termination of pregnancy among women with one or more previous cesarean deliveries. METHODS In a retrospective study, data were reviewed from women attending a reproductive health clinic in Bloemfontein, South Africa, for second-trimester termination between 2010 and 2013. The study group, comprising women with one or more previous cesareans, was compared with a control group, comprising women with no previous cesarean or uterine scarring. Procedure-specific information was compared, including misoprostol use, termination duration, need for other methods (e.g. oxytocin), placenta delivery, termination outcome, and bleeding. RESULTS The study group comprised 268 women: 231 (86.2%) with one and 37 (13.8%) with two previous cesareans. The control group comprised 266 women. Incomplete abortion was recorded in 223 (85.4%) of 261 women in the study group and 213 (80.4%) of 265 in the control group. The number of women with retained placenta was higher in the study than in the control group (158/261 [60.5%] vs 146/265 [55.1%]; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text